Investing.com - Gilead (NASDAQ:GILD) reported on Thursday first quarter earnings that beat analysts' forecasts and revenue that topped expectations.
Gilead announced earnings per share of $1.68 on revenue of $5.55B. Analysts polled by Investing.com anticipated EPS of $1.59 on revenue of $5.46B. That with comparison to EPS of $1.76 on revenue of $5.28B in the same period a year before.Gilead had reported EPS of $1.3 on revenue of $5.88B in the previous quarter.Analysts are expecting EPS of $1.61 and revenue of $5.56B in the upcoming quarter.
Gilead shares are up 28% from the beginning of the year and are trading at $85.00 , down-from-52-week-high.They are outperforming the Nasdaq which is down 1.66% year to date.
Gilead shares gained 1.49% in after-hours trade after the report.
Gilead follows other major Healthcare sector earnings this month
Gilead's report follows an earnings beat by J&J on Tuesday, April 14, 2020, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Pfizer had beat expectations on Tuesday with first quarter EPS of $0.8 on revenue of $12.03B, compared to forecast for EPS of $0.7 on revenue of $11.34B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar